Edwards Lifesciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care.

CEO

Bernard J. Zovighian

CEOBernard J. Zovighian

Employees

16,000

Employees16,000

Headquarters

Irvine, California

HeadquartersIrvine, California

Founded

1958

Founded1958

Employees

16,000

Employees16,000

EW Key Statistics

Market cap

47.52B

Market cap47.52B

Price-Earnings ratio

45.21

Price-Earnings ratio45.21

Dividend yield

—

Dividend yield—

Average volume

5.06M

Average volume5.06M

High today

$85.33

High today$85.33

Low today

$81.35

Low today$81.35

Open price

$85.33

Open price$85.33

Volume

5.59M

Volume5.59M

52 Week high

$87.89

52 Week high$87.89

52 Week low

$65.94

52 Week low$65.94

Stock Snapshot

As of today, Edwards Lifesciences(EW) shares are valued at $82.00. The company's market cap stands at 47.52B, with a P/E ratio of 45.21.

As of 2026-03-15, Edwards Lifesciences(EW) stock has fluctuated between $81.35 and $85.33. The current price stands at $82.00, placing the stock +0.8% above today's low and -3.9% off the high.

Edwards Lifesciences(EW) shares are trading with a volume of 5.59M, against a daily average of 5.06M.

In the last year, Edwards Lifesciences(EW) shares hit a 52-week high of $87.89 and a 52-week low of $65.94.

EW News

Nasdaq 2d

Edwards Lifesciences Stock Up 22.1% in a Year: What's Driving It?

Edwards Lifesciences EW has delivered an impressive return over the past year, with shares rallying 22.1%. The stock comfortably outpaced the industry’s 3.8% fa...

Simply Wall St 3d

A Look At Edwards Lifesciences Valuation As It Exits Critical Care To Focus On Core Heart Therapies

Edwards Lifesciences (EW) has been back in focus after moving to sell its critical care unit and to concentrate on areas such as asymptomatic aortic stenosis an...

Simply Wall St 5d

Edwards’ Critical Care Exit And New Policy Hire Might Change The Case For Investing In EW

Edwards Lifesciences recently appointed Niranjan Pai, formerly a director at APCO with prior experience at Ernst & Young, as Director-Government Affairs, while...

Analyst ratings

67%

of 33 ratings

Buy

66.7%

Hold

33.3%

Sell

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.